Clinical Trial Detail

NCT ID NCT04314089
Title Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Edward Patz
Indications

lung non-small cell carcinoma

Therapies

GT103

Age Groups: adult senior

No variant requirements are available.